Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer

Innate Immunity

Volumn 19, Issue 3, 2013, Pages 328-336

  Trellakis, Sokratis ^a   Bruderek, Kirsten ^a   Hütte, Jan ^a   Elian, Motaz ^a   Hoffmann, Thomas K ^a   Lang, Stephan ^a   Brandau, Sven ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cryopreservation; CXCL8; granulocyte macrophage colony stimulating factor; granulocyte colony stimulating factor; immune monitoring; peripheral blood

Indexed keywords

CALGRANULIN A; CARBON TETRACHLORIDE; CD14 ANTIGEN; CD33 ANTIGEN; COLONY STIMULATING FACTOR; CXCL1 CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL TYPE; CORRELATIONAL STUDY; CRYOPRESERVATION; DISEASE COURSE; FREEZE THAWING; GENE FREQUENCY; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMATURITY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; SUPPRESSOR CELL; BLOOD; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; GRANULOCYTE; HEAD AND NECK TUMOR; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; PATHOLOGY; PROCEDURES;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL4; COLONY-STIMULATING FACTORS; CRYOPRESERVATION; GRANULOCYTES; HEAD AND NECK NEOPLASMS; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-8; MYELOID CELLS;

EID: 84877766429     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912463618     Document Type: Article

References (29)

1. Peranzoni E, Zilio S, Marigo I, et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol. 2010 ; 22: 238-244
2. Zea AH, Rodriguez PC, Atkins MB, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005 ; 65: 3044-3048
3. Filipazzi P, Valenti R, Huber V, et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol. 2007 ; 25: 2546-2553
4. Almand B, Clark JI, Nikitina E, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol. 2001 ; 166: 678-689
5. Greten TF, Manns MP, Korangy F. Myeloid derived suppressor cells in human diseases. Int Immunopharmacol. 2011 ; 11: 802-806
6. Dumitru CA, Moses K, Trellakis S, et al. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother. 2012 ; 61: 1155-1167
7. Solito S, Falisi E, Diaz-Montero CM, et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood. 2011 ; 118: 2254-2265
8. Gabitass RF, Annels NE, Stocken DD, et al. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother. 2011 ; 60: 1419-1430
9. Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 2011 ; 32: 19-25
10. Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010 ; 185: 2273-2284
11. Waight JD, Hu Q, Miller A, et al. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE. 2011 ; 6: e27690 - e27690
12. Kotsakis A, Harasymczuk M, Schilling B, et al. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J Immunol Methods. 2012 ; 381: 14-22
13. Brandau S, Trellakis S, Bruderek K, et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol. 2011 ; 89: 311-317
14. Majado MJ, Salgado-Cecilia G, Blanquer M, et al. Cryopreservation impact on blood progenitor cells: influence of diagnoses, mobilization treatments, and cell concentration. Transfusion. 2011 ; 51: 799-807
15. Mundy-Bosse BL, Young GS, Bauer T, et al. Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4(+) T cells from patients with GI malignancy. Cancer Immunol Immunother. 2011 ; 60: 1269-1279
16. Diaz-Montero CM, Salem ML, Nishimura MI, et al. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009 ; 58: 49-59
17. Trellakis S, Bruderek K, Dumitru CA, et al. Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2011 ; 129: 2183-2193
18. Sinha P, Okoro C, Foell D, et al. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol. 2008 ; 181: 4666-4675
19. Zhao F, Hoechst B, Duffy A, et al. S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology. 2012 ; 136: 176-183
20. Trellakis S, Farjah H, Bruderek K, et al. Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors. Int J Immunopathol Pharmacol. 2011 ; 24: 683-693
21. Raychaudhuri B, Rayman P, Ireland J, et al. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol. 2011 ; 13: 591-599
22. Wengner AM, Pitchford SC, Furze RC, et al. The coordinated action of G-CSF and ELR+CXC chemokines in neutrophil mobilization during acute inflammation. Blood. 2008 ; 111: 42-49
23. Kohler A, De FK, Hasenberg M, et al. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood. 2011 ; 117: 4349-4357
24. Luyckx A, Schouppe E, Rutgeerts O, et al. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol. 2012 ; 143: 83-87
25. Bozic CR, Gerard NP, von Uexkull-Guldenband C, et al. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem. 1994 ; 269: 29355-29358
26. Yokoigawa N, Takeuchi N, Toda M, et al. Enhanced production of interleukin 6 in peripheral blood monocytes stimulated with mucins secreted into the bloodstream. Clin Cancer Res. 2005 ; 11: 6127-6132
27. Eruslanov E, Neuberger M, Daurkin I, et al. Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer. 2012 ; 130: 1109-1119
28. Rodriguez PC, Ernstoff MS, Hernandez C, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009 ; 69: 1553-1560
29. Chornoguz O, Grmai L, Sinha P, et al. Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis. Mol Cell Proteomics. 2011 ; 10: M110 - M110